Nedira Salzman-Frenkel, based in Israel, is currently a Vice President of Business Development at NeuroSense Therapeutics, bringing experience from previous roles at Salzman Group, SOLIVA, Beetlebung Pharmaceuticals and Salzman Capital Ventures. Nedira Salzman-Frenkel holds a 2015 - 2017 Master of Business Administration (MBA) in Entrepreneurship & Strategy @ Tel Aviv University - Coller School of Management. Nedira Salzman-Frenkel has 1 email on RocketReach.